GeneScience | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Data insights

29 January 2025

NextCure joins the B7-H4 brigade

Meanwhile, Olema’s KAT6 inhibitor will take on rival projects from Pfizer and Menarini.

Subscribe to GeneScience